[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$ffQQ45zKXSqaNDzv7k95YtYykZhRJnbBIJrt9_Ip3gq8":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":49,"rows":56},"Wolfson Medical Center",[4],112,false,12,6,11651,4,77,[14,17,19,22,24,27,29,31],{"name":15,"count":16},"Anxiety",5,{"name":18,"count":11},"Ulcerative Colitis",{"name":20,"count":21},"Asthma",3,{"name":23,"count":21},"ARDS",{"name":25,"count":26},"Pain",2,{"name":28,"count":26},"Obesity",{"name":30,"count":26},"Induction of Labor Affected Fetus \u002F Newborn",{"name":32,"count":26},"ART",[34,39,44],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT05791487","Combination of Diet and Oral Budesonide for Ulcerative Colitis","2026-03-01","Oral Budesonide",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06950840","Antipyretic Treatment for Intrapartum Fever: Dipyrone vs Acetaminophen (RCT)","2027-05-01","Acetaminophen",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT07362992","Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery","2027-12-01","Tranexamic Acid",[50,51,52,53,54,55],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[57,101,123,159,183,209,235,261,285,310,335,361,379,397,415,433,461,479,502,520,546,573,591,613,640,658,684,706,729,754,780,798,847,873,891,915,933,957,982,1007,1025,1051,1076],{"intervention":43,"totalTrials":26,"cells":58},{"EARLY_PHASE1":59,"PHASE1":62,"PHASE2":64,"PHASE3":66,"PHASE4":68,"NA":99},{"trials":60,"activeCount":61},[],0,{"trials":63,"activeCount":61},[],{"trials":65,"activeCount":61},[],{"trials":67,"activeCount":61},[],{"trials":69,"activeCount":98,"soonestReadout":42},[70,87],{"nctId":71,"briefTitle":72,"status":73,"phases":74,"primaryCompletion":75,"completion":75,"start":76,"enrollment":77,"conditions":78,"interventions":81},"NCT03622489","Comparing Protocols for Analgesia Following Elective Cesarean Section","UNKNOWN",[54],"2018-08-31","2017-03-01",120,[79,80],"Postoperative Pain","Post-Cesarean Section",[43,82,83,84,85,86],"Ibuprofen 400 mg","Dipyrone","Tramadol","Morphine","Tramal",{"nctId":40,"briefTitle":41,"status":88,"phases":89,"primaryCompletion":42,"completion":90,"start":91,"enrollment":92,"conditions":93,"interventions":96},"NOT_YET_RECRUITING",[54],"2027-05","2025-08-01",140,[94,95],"Intrapartum Fever","Chorioamnionitis",[43,97],"dipyrone",1,{"trials":100,"activeCount":61},[],{"intervention":83,"totalTrials":26,"cells":102},{"EARLY_PHASE1":103,"PHASE1":105,"PHASE2":107,"PHASE3":109,"PHASE4":111,"NA":121},{"trials":104,"activeCount":61},[],{"trials":106,"activeCount":61},[],{"trials":108,"activeCount":61},[],{"trials":110,"activeCount":61},[],{"trials":112,"activeCount":98,"soonestReadout":42},[113,117],{"nctId":71,"briefTitle":72,"status":73,"phases":114,"primaryCompletion":75,"completion":75,"start":76,"enrollment":77,"conditions":115,"interventions":116},[54],[79,80],[43,82,83,84,85,86],{"nctId":40,"briefTitle":41,"status":88,"phases":118,"primaryCompletion":42,"completion":90,"start":91,"enrollment":92,"conditions":119,"interventions":120},[54],[94,95],[43,97],{"trials":122,"activeCount":61},[],{"intervention":48,"totalTrials":26,"cells":124},{"EARLY_PHASE1":125,"PHASE1":137,"PHASE2":139,"PHASE3":141,"PHASE4":143,"NA":145},{"trials":126,"activeCount":98,"soonestReadout":47},[127],{"nctId":45,"briefTitle":46,"status":88,"phases":128,"primaryCompletion":47,"completion":129,"start":130,"enrollment":6,"conditions":131,"interventions":136},[50],"2027-12-31","2026-01-01",[132,133,134,135],"Cesarean Delivery","Postpartum Hemorrhage (PPH)","Intraoperative Blood Loss","Hemostasis",[48],{"trials":138,"activeCount":61},[],{"trials":140,"activeCount":61},[],{"trials":142,"activeCount":61},[],{"trials":144,"activeCount":61},[],{"trials":146,"activeCount":61},[147],{"nctId":148,"briefTitle":149,"status":73,"phases":150,"primaryCompletion":151,"completion":152,"start":153,"enrollment":154,"conditions":155,"interventions":157},"NCT05921071","Do Patients Who Received Tranexamic Acid in Vaginal Hysterectomy Loose Les Blood, Comparing to Patients Who Did Not?",[55],"2024-06-01","2025-01-01","2023-01-22",80,[156],"Vaginal Hysterectomy",[158],"Tranexamic acid",{"intervention":38,"totalTrials":98,"cells":160},{"EARLY_PHASE1":161,"PHASE1":163,"PHASE2":165,"PHASE3":167,"PHASE4":169,"NA":171},{"trials":162,"activeCount":61},[],{"trials":164,"activeCount":61},[],{"trials":166,"activeCount":61},[],{"trials":168,"activeCount":61},[],{"trials":170,"activeCount":61},[],{"trials":172,"activeCount":98,"soonestReadout":37},[173],{"nctId":35,"briefTitle":36,"status":174,"phases":175,"primaryCompletion":37,"completion":176,"start":177,"enrollment":178,"conditions":179,"interventions":182},"RECRUITING",[55],"2026-09-01","2023-12-01",90,[18,180,181],"Ulcerative Colitis Chronic Mild","Ulcerative Colitis Chronic Moderate",[38],{"intervention":184,"totalTrials":98,"cells":185},"Testosterone gel",{"EARLY_PHASE1":186,"PHASE1":188,"PHASE2":190,"PHASE3":192,"PHASE4":194,"NA":207},{"trials":187,"activeCount":61},[],{"trials":189,"activeCount":61},[],{"trials":191,"activeCount":61},[],{"trials":193,"activeCount":61},[],{"trials":195,"activeCount":61},[196],{"nctId":197,"briefTitle":198,"status":73,"phases":199,"primaryCompletion":200,"completion":201,"start":202,"enrollment":203,"conditions":204,"interventions":206},"NCT03078569","Transdermal Testosterone for Poor Responder Patients Undergoing Controlled Ovarian Stimulation Prior to IVF",[54],"2018-03","2018-07","2017-03",30,[205],"Infertility, Female",[184],{"trials":208,"activeCount":61},[],{"intervention":210,"totalTrials":98,"cells":211},"Mesalamine",{"EARLY_PHASE1":212,"PHASE1":214,"PHASE2":216,"PHASE3":218,"PHASE4":220,"NA":233},{"trials":213,"activeCount":61},[],{"trials":215,"activeCount":61},[],{"trials":217,"activeCount":61},[],{"trials":219,"activeCount":61},[],{"trials":221,"activeCount":61},[222],{"nctId":223,"briefTitle":224,"status":225,"phases":226,"primaryCompletion":227,"completion":227,"start":228,"enrollment":229,"conditions":230,"interventions":232},"NCT01201122","Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis","COMPLETED",[54],"2015-12","2010-09",86,[231],"Mild to Moderate Ulcerative Colitis",[210],{"trials":234,"activeCount":61},[],{"intervention":236,"totalTrials":98,"cells":237},"valproic acid",{"EARLY_PHASE1":238,"PHASE1":240,"PHASE2":242,"PHASE3":244,"PHASE4":246,"NA":259},{"trials":239,"activeCount":61},[],{"trials":241,"activeCount":61},[],{"trials":243,"activeCount":61},[],{"trials":245,"activeCount":61},[],{"trials":247,"activeCount":61},[248],{"nctId":249,"briefTitle":250,"status":225,"phases":251,"primaryCompletion":252,"completion":253,"start":254,"enrollment":255,"conditions":256,"interventions":258},"NCT01115959","Seizures Post Intracerebral Hemorrhage",[54],"2008-10","2008-12","2003-02",72,[257],"Post Cerebral Hemorrhage",[236],{"trials":260,"activeCount":61},[],{"intervention":262,"totalTrials":98,"cells":263},"Melatonin",{"EARLY_PHASE1":264,"PHASE1":266,"PHASE2":268,"PHASE3":270,"PHASE4":272,"NA":283},{"trials":265,"activeCount":61},[],{"trials":267,"activeCount":61},[],{"trials":269,"activeCount":61},[],{"trials":271,"activeCount":61},[],{"trials":273,"activeCount":61},[274],{"nctId":275,"briefTitle":276,"status":73,"phases":277,"primaryCompletion":278,"start":279,"enrollment":92,"conditions":280,"interventions":282},"NCT01863277","Safety Study of Melatonin in Stroke Patients",[54],"2014-04","2013-07",[281],"Acute Ischemic Stroke",[262],{"trials":284,"activeCount":61},[],{"intervention":286,"totalTrials":98,"cells":287},"Prostin (PGE2)",{"EARLY_PHASE1":288,"PHASE1":290,"PHASE2":292,"PHASE3":294,"PHASE4":296,"NA":308},{"trials":289,"activeCount":61},[],{"trials":291,"activeCount":61},[],{"trials":293,"activeCount":61},[],{"trials":295,"activeCount":61},[],{"trials":297,"activeCount":61},[298],{"nctId":299,"briefTitle":300,"status":73,"phases":301,"primaryCompletion":302,"completion":302,"start":303,"enrollment":304,"conditions":305,"interventions":307},"NCT02486679","A Trial of Prostaglandin E2 Tablets Versus Foley Catheter for Labor Induction",[54],"2017-07","2015-07",300,[306],"Labor, Induced",[286],{"trials":309,"activeCount":61},[],{"intervention":311,"totalTrials":98,"cells":312},"Exjade",{"EARLY_PHASE1":313,"PHASE1":315,"PHASE2":317,"PHASE3":319,"PHASE4":321,"NA":333},{"trials":314,"activeCount":61},[],{"trials":316,"activeCount":61},[],{"trials":318,"activeCount":61},[],{"trials":320,"activeCount":61},[],{"trials":322,"activeCount":61},[323],{"nctId":324,"briefTitle":325,"status":225,"phases":326,"primaryCompletion":327,"completion":327,"start":328,"enrollment":329,"conditions":330,"interventions":332},"NCT00452660","Evaluation the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over Load",[54],"2008-08","2007-05",21,[331],"Myelodysplastic Syndrome",[311],{"trials":334,"activeCount":61},[],{"intervention":336,"totalTrials":98,"cells":337},"Spironolactone",{"EARLY_PHASE1":338,"PHASE1":340,"PHASE2":342,"PHASE3":344,"PHASE4":346,"NA":359},{"trials":339,"activeCount":61},[],{"trials":341,"activeCount":61},[],{"trials":343,"activeCount":61},[],{"trials":345,"activeCount":61},[],{"trials":347,"activeCount":61},[348],{"nctId":349,"briefTitle":350,"status":225,"phases":351,"primaryCompletion":352,"completion":352,"start":353,"enrollment":354,"conditions":355,"interventions":358},"NCT01089309","Effect of Aldosterone Blockade on Arterial Compliance",[54],"2007-06","2004-05",51,[356,357],"Arterial Stiffness","Arterial Elasticity",[336],{"trials":360,"activeCount":61},[],{"intervention":82,"totalTrials":98,"cells":362},{"EARLY_PHASE1":363,"PHASE1":365,"PHASE2":367,"PHASE3":369,"PHASE4":371,"NA":377},{"trials":364,"activeCount":61},[],{"trials":366,"activeCount":61},[],{"trials":368,"activeCount":61},[],{"trials":370,"activeCount":61},[],{"trials":372,"activeCount":61},[373],{"nctId":71,"briefTitle":72,"status":73,"phases":374,"primaryCompletion":75,"completion":75,"start":76,"enrollment":77,"conditions":375,"interventions":376},[54],[79,80],[43,82,83,84,85,86],{"trials":378,"activeCount":61},[],{"intervention":84,"totalTrials":98,"cells":380},{"EARLY_PHASE1":381,"PHASE1":383,"PHASE2":385,"PHASE3":387,"PHASE4":389,"NA":395},{"trials":382,"activeCount":61},[],{"trials":384,"activeCount":61},[],{"trials":386,"activeCount":61},[],{"trials":388,"activeCount":61},[],{"trials":390,"activeCount":61},[391],{"nctId":71,"briefTitle":72,"status":73,"phases":392,"primaryCompletion":75,"completion":75,"start":76,"enrollment":77,"conditions":393,"interventions":394},[54],[79,80],[43,82,83,84,85,86],{"trials":396,"activeCount":61},[],{"intervention":85,"totalTrials":98,"cells":398},{"EARLY_PHASE1":399,"PHASE1":401,"PHASE2":403,"PHASE3":405,"PHASE4":407,"NA":413},{"trials":400,"activeCount":61},[],{"trials":402,"activeCount":61},[],{"trials":404,"activeCount":61},[],{"trials":406,"activeCount":61},[],{"trials":408,"activeCount":61},[409],{"nctId":71,"briefTitle":72,"status":73,"phases":410,"primaryCompletion":75,"completion":75,"start":76,"enrollment":77,"conditions":411,"interventions":412},[54],[79,80],[43,82,83,84,85,86],{"trials":414,"activeCount":61},[],{"intervention":86,"totalTrials":98,"cells":416},{"EARLY_PHASE1":417,"PHASE1":419,"PHASE2":421,"PHASE3":423,"PHASE4":425,"NA":431},{"trials":418,"activeCount":61},[],{"trials":420,"activeCount":61},[],{"trials":422,"activeCount":61},[],{"trials":424,"activeCount":61},[],{"trials":426,"activeCount":61},[427],{"nctId":71,"briefTitle":72,"status":73,"phases":428,"primaryCompletion":75,"completion":75,"start":76,"enrollment":77,"conditions":429,"interventions":430},[54],[79,80],[43,82,83,84,85,86],{"trials":432,"activeCount":61},[],{"intervention":434,"totalTrials":98,"cells":435},"Alirocumab Injectable Product",{"EARLY_PHASE1":436,"PHASE1":438,"PHASE2":440,"PHASE3":442,"PHASE4":457,"NA":459},{"trials":437,"activeCount":61},[],{"trials":439,"activeCount":61},[],{"trials":441,"activeCount":61},[],{"trials":443,"activeCount":61},[444],{"nctId":445,"briefTitle":446,"status":73,"phases":447,"primaryCompletion":448,"completion":449,"start":450,"enrollment":451,"conditions":452,"interventions":455},"NCT03634293","Treatment of Severe Infection With Antihyperlipidemia Drug",[52,53],"2021-01","2021-02","2019-01",712,[453,454],"Sepsis","Septic Shock",[434,456],"Saline Solution",{"trials":458,"activeCount":61},[],{"trials":460,"activeCount":61},[],{"intervention":456,"totalTrials":98,"cells":462},{"EARLY_PHASE1":463,"PHASE1":465,"PHASE2":467,"PHASE3":469,"PHASE4":475,"NA":477},{"trials":464,"activeCount":61},[],{"trials":466,"activeCount":61},[],{"trials":468,"activeCount":61},[],{"trials":470,"activeCount":61},[471],{"nctId":445,"briefTitle":446,"status":73,"phases":472,"primaryCompletion":448,"completion":449,"start":450,"enrollment":451,"conditions":473,"interventions":474},[52,53],[453,454],[434,456],{"trials":476,"activeCount":61},[],{"trials":478,"activeCount":61},[],{"intervention":480,"totalTrials":98,"cells":481},"CROMOLYN",{"EARLY_PHASE1":482,"PHASE1":484,"PHASE2":486,"PHASE3":488,"PHASE4":498,"NA":500},{"trials":483,"activeCount":61},[],{"trials":485,"activeCount":61},[],{"trials":487,"activeCount":61},[],{"trials":489,"activeCount":61},[490],{"nctId":491,"briefTitle":492,"status":73,"phases":493,"conditions":494,"interventions":496},"NCT01175525","Treatment of Acute Stroke With Cromolyn(Single Dose)",[53],[495],"Acute Stroke",[480,497],"sugar pill",{"trials":499,"activeCount":61},[],{"trials":501,"activeCount":61},[],{"intervention":497,"totalTrials":98,"cells":503},{"EARLY_PHASE1":504,"PHASE1":506,"PHASE2":508,"PHASE3":510,"PHASE4":516,"NA":518},{"trials":505,"activeCount":61},[],{"trials":507,"activeCount":61},[],{"trials":509,"activeCount":61},[],{"trials":511,"activeCount":61},[512],{"nctId":491,"briefTitle":492,"status":73,"phases":513,"conditions":514,"interventions":515},[53],[495],[480,497],{"trials":517,"activeCount":61},[],{"trials":519,"activeCount":61},[],{"intervention":521,"totalTrials":98,"cells":522},"MTR107",{"EARLY_PHASE1":523,"PHASE1":525,"PHASE2":527,"PHASE3":540,"PHASE4":542,"NA":544},{"trials":524,"activeCount":61},[],{"trials":526,"activeCount":61},[],{"trials":528,"activeCount":61},[529],{"nctId":530,"briefTitle":531,"status":73,"phases":532,"completion":533,"start":534,"enrollment":8,"conditions":535,"interventions":539},"NCT00448071","Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients",[52],"2007-03","2006-05",[536,537,538],"Hypotension","End Stage Renal Disease","Intra Dialytic Hypotension",[521],{"trials":541,"activeCount":61},[],{"trials":543,"activeCount":61},[],{"trials":545,"activeCount":61},[],{"intervention":547,"totalTrials":98,"cells":548},"amoxicillin, metronidazole and doxycycline",{"EARLY_PHASE1":549,"PHASE1":551,"PHASE2":553,"PHASE3":567,"PHASE4":569,"NA":571},{"trials":550,"activeCount":61},[],{"trials":552,"activeCount":61},[],{"trials":554,"activeCount":61},[555],{"nctId":556,"briefTitle":557,"status":558,"phases":559,"primaryCompletion":560,"completion":561,"start":562,"enrollment":563,"conditions":564,"interventions":565},"NCT03986996","Antimicrobial Therapy for Ulcerative Colitis (UC)","TERMINATED",[52],"2022-05-29","2022-05-30","2019-07-25",20,[18],[547,566],"amoxicillin and doxycyclin",{"trials":568,"activeCount":61},[],{"trials":570,"activeCount":61},[],{"trials":572,"activeCount":61},[],{"intervention":566,"totalTrials":98,"cells":574},{"EARLY_PHASE1":575,"PHASE1":577,"PHASE2":579,"PHASE3":585,"PHASE4":587,"NA":589},{"trials":576,"activeCount":61},[],{"trials":578,"activeCount":61},[],{"trials":580,"activeCount":61},[581],{"nctId":556,"briefTitle":557,"status":558,"phases":582,"primaryCompletion":560,"completion":561,"start":562,"enrollment":563,"conditions":583,"interventions":584},[52],[18],[547,566],{"trials":586,"activeCount":61},[],{"trials":588,"activeCount":61},[],{"trials":590,"activeCount":61},[],{"intervention":592,"totalTrials":98,"cells":593},"Metformin",{"EARLY_PHASE1":594,"PHASE1":596,"PHASE2":598,"PHASE3":607,"PHASE4":609,"NA":611},{"trials":595,"activeCount":61},[],{"trials":597,"activeCount":61},[],{"trials":599,"activeCount":61},[600],{"nctId":601,"briefTitle":602,"status":225,"phases":603,"conditions":604,"interventions":606},"NCT01084486","Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver Disease",[51,52],[605],"Nonalcoholic Fatty Liver Disease",[592],{"trials":608,"activeCount":61},[],{"trials":610,"activeCount":61},[],{"trials":612,"activeCount":61},[],{"intervention":614,"totalTrials":98,"cells":615},"Avidekel oil",{"EARLY_PHASE1":616,"PHASE1":618,"PHASE2":620,"PHASE3":634,"PHASE4":636,"NA":638},{"trials":617,"activeCount":61},[],{"trials":619,"activeCount":61},[],{"trials":621,"activeCount":61},[622],{"nctId":623,"briefTitle":624,"status":73,"phases":625,"primaryCompletion":626,"completion":627,"start":303,"enrollment":628,"conditions":629,"interventions":632},"NCT02470325","The Effects of Cannabis on Dystonia and Spasticity on Pediatric Patients",[52],"2016-12","2017-12",40,[630,631],"Spasticity","Dystonia",[614,633],"Enriched Avidekel oil",{"trials":635,"activeCount":61},[],{"trials":637,"activeCount":61},[],{"trials":639,"activeCount":61},[],{"intervention":633,"totalTrials":98,"cells":641},{"EARLY_PHASE1":642,"PHASE1":644,"PHASE2":646,"PHASE3":652,"PHASE4":654,"NA":656},{"trials":643,"activeCount":61},[],{"trials":645,"activeCount":61},[],{"trials":647,"activeCount":61},[648],{"nctId":623,"briefTitle":624,"status":73,"phases":649,"primaryCompletion":626,"completion":627,"start":303,"enrollment":628,"conditions":650,"interventions":651},[52],[630,631],[614,633],{"trials":653,"activeCount":61},[],{"trials":655,"activeCount":61},[],{"trials":657,"activeCount":61},[],{"intervention":659,"totalTrials":98,"cells":660},"Rituximab",{"EARLY_PHASE1":661,"PHASE1":663,"PHASE2":665,"PHASE3":678,"PHASE4":680,"NA":682},{"trials":662,"activeCount":61},[],{"trials":664,"activeCount":61},[],{"trials":666,"activeCount":61},[667],{"nctId":668,"briefTitle":669,"status":73,"phases":670,"primaryCompletion":671,"completion":672,"start":673,"enrollment":674,"conditions":675,"interventions":677},"NCT00892827","Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia",[52],"2009-07","2010-12","2009-04",10,[676],"Advanced Refractory Chronic Lymphocytic Leukemia",[659],{"trials":679,"activeCount":61},[],{"trials":681,"activeCount":61},[],{"trials":683,"activeCount":61},[],{"intervention":685,"totalTrials":98,"cells":686},"Cetrotide",{"EARLY_PHASE1":687,"PHASE1":689,"PHASE2":691,"PHASE3":700,"PHASE4":702,"NA":704},{"trials":688,"activeCount":61},[],{"trials":690,"activeCount":61},[],{"trials":692,"activeCount":61},[693],{"nctId":694,"briefTitle":695,"status":696,"phases":697,"enrollment":61,"conditions":698,"interventions":699},"NCT01109888","Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS)","WITHDRAWN",[51,52],[695],[685],{"trials":701,"activeCount":61},[],{"trials":703,"activeCount":61},[],{"trials":705,"activeCount":61},[],{"intervention":707,"totalTrials":98,"cells":708},"Cannabis",{"EARLY_PHASE1":709,"PHASE1":711,"PHASE2":721,"PHASE3":723,"PHASE4":725,"NA":727},{"trials":710,"activeCount":61},[],{"trials":712,"activeCount":61},[713],{"nctId":714,"briefTitle":715,"status":696,"phases":716,"primaryCompletion":626,"start":717,"enrollment":61,"conditions":718,"interventions":720},"NCT01969474","Effectiveness of Cannabis in the Treatment of Tinnitus Patients",[51],"2013-12",[719],"Tinnitus",[707],{"trials":722,"activeCount":61},[],{"trials":724,"activeCount":61},[],{"trials":726,"activeCount":61},[],{"trials":728,"activeCount":61},[],{"intervention":730,"totalTrials":98,"cells":731},"Vaginal tablet Endometrin twice a day",{"EARLY_PHASE1":732,"PHASE1":744,"PHASE2":746,"PHASE3":748,"PHASE4":750,"NA":752},{"trials":733,"activeCount":61},[734],{"nctId":735,"briefTitle":736,"status":73,"phases":737,"primaryCompletion":738,"completion":738,"start":739,"enrollment":740,"conditions":741,"interventions":743},"NCT01483365","The Need for Luteal Support in NC-FET",[50],"2014-12","2011-12",100,[742],"Abnormal Menstrual Cycle",[730],{"trials":745,"activeCount":61},[],{"trials":747,"activeCount":61},[],{"trials":749,"activeCount":61},[],{"trials":751,"activeCount":61},[],{"trials":753,"activeCount":61},[],{"intervention":755,"totalTrials":98,"cells":756},"Marcaine 0.5 % Injectable Solution",{"EARLY_PHASE1":757,"PHASE1":770,"PHASE2":772,"PHASE3":774,"PHASE4":776,"NA":778},{"trials":758,"activeCount":61},[759],{"nctId":760,"briefTitle":761,"status":225,"phases":762,"primaryCompletion":763,"completion":763,"start":764,"enrollment":765,"conditions":766,"interventions":768},"NCT03268525","The Effect of Local Anesthesia on Postoperative Pain in Vaginal Hysterectomy",[50],"2019-11-30","2017-09-01",60,[767],"Pain, Postoperative",[755,769],"Sodium Chloride 0.9%",{"trials":771,"activeCount":61},[],{"trials":773,"activeCount":61},[],{"trials":775,"activeCount":61},[],{"trials":777,"activeCount":61},[],{"trials":779,"activeCount":61},[],{"intervention":769,"totalTrials":98,"cells":781},{"EARLY_PHASE1":782,"PHASE1":788,"PHASE2":790,"PHASE3":792,"PHASE4":794,"NA":796},{"trials":783,"activeCount":61},[784],{"nctId":760,"briefTitle":761,"status":225,"phases":785,"primaryCompletion":763,"completion":763,"start":764,"enrollment":765,"conditions":786,"interventions":787},[50],[767],[755,769],{"trials":789,"activeCount":61},[],{"trials":791,"activeCount":61},[],{"trials":793,"activeCount":61},[],{"trials":795,"activeCount":61},[],{"trials":797,"activeCount":61},[],{"intervention":799,"totalTrials":11,"cells":800},"Misoprostol",{"EARLY_PHASE1":801,"PHASE1":803,"PHASE2":805,"PHASE3":807,"PHASE4":809,"NA":835},{"trials":802,"activeCount":61},[],{"trials":804,"activeCount":61},[],{"trials":806,"activeCount":61},[],{"trials":808,"activeCount":61},[],{"trials":810,"activeCount":61},[811,819,826],{"nctId":812,"briefTitle":813,"status":73,"phases":814,"primaryCompletion":815,"completion":815,"start":303,"enrollment":77,"conditions":816,"interventions":818},"NCT02480543","Different Routes of Misoprostol Prior to First Trimester Surgical Abortion",[54],"2016-07",[817],"Abortion, Induced",[799],{"nctId":820,"briefTitle":821,"status":73,"phases":822,"primaryCompletion":302,"completion":302,"start":303,"enrollment":77,"conditions":823,"interventions":825},"NCT02474433","Same-day Cervical Preparation With Misoprostol Before Hysteroscopy",[54],[824],"Cervical Preparation Prior to Hysteroscopy",[799],{"nctId":827,"briefTitle":828,"status":225,"phases":829,"primaryCompletion":815,"completion":815,"start":830,"enrollment":831,"conditions":832,"interventions":834},"NCT02515604","Comparison of Single and Repeated Dose of Vaginal Misoprostol for the Treatment of Early Pregnancy Failure",[54],"2015-08",180,[833],"Abortion, Missed",[799],{"trials":836,"activeCount":61},[837],{"nctId":838,"briefTitle":839,"status":225,"phases":840,"primaryCompletion":841,"completion":841,"start":842,"enrollment":843,"conditions":844,"interventions":846},"NCT01678703","Comparison of Laminaria and Misoprostol for Cervical Preparation Before Second Trimester Surgical Abortion",[55],"2010-06","2007-11",84,[845],"Induced; Abortion, Nonmedical",[799],{"intervention":848,"totalTrials":98,"cells":849},"Diclofenac",{"EARLY_PHASE1":850,"PHASE1":852,"PHASE2":854,"PHASE3":856,"PHASE4":858,"NA":860},{"trials":851,"activeCount":61},[],{"trials":853,"activeCount":61},[],{"trials":855,"activeCount":61},[],{"trials":857,"activeCount":61},[],{"trials":859,"activeCount":61},[],{"trials":861,"activeCount":61},[862],{"nctId":863,"briefTitle":864,"status":73,"phases":865,"primaryCompletion":866,"start":303,"enrollment":203,"conditions":867,"interventions":871},"NCT02506348","Comparison of Diclofenac vs. Nepafenac Ophthalmic Drops: Patient Comfort",[55],"2016-01",[868,869,870],"Post Surgical Management","Pain Management","Inflamation Management",[848,872],"Nepafenac",{"intervention":872,"totalTrials":98,"cells":874},{"EARLY_PHASE1":875,"PHASE1":877,"PHASE2":879,"PHASE3":881,"PHASE4":883,"NA":885},{"trials":876,"activeCount":61},[],{"trials":878,"activeCount":61},[],{"trials":880,"activeCount":61},[],{"trials":882,"activeCount":61},[],{"trials":884,"activeCount":61},[],{"trials":886,"activeCount":61},[887],{"nctId":863,"briefTitle":864,"status":73,"phases":888,"primaryCompletion":866,"start":303,"enrollment":203,"conditions":889,"interventions":890},[55],[868,869,870],[848,872],{"intervention":892,"totalTrials":98,"cells":893},"Dydrogesterone 10 MG",{"EARLY_PHASE1":894,"PHASE1":896,"PHASE2":898,"PHASE3":900,"PHASE4":902,"NA":904},{"trials":895,"activeCount":61},[],{"trials":897,"activeCount":61},[],{"trials":899,"activeCount":61},[],{"trials":901,"activeCount":61},[],{"trials":903,"activeCount":61},[],{"trials":905,"activeCount":61},[906],{"nctId":907,"briefTitle":908,"status":73,"phases":909,"primaryCompletion":910,"completion":910,"start":911,"enrollment":740,"conditions":912,"interventions":913},"NCT03832699","Oral Dydrogesterone vs. Vaginal Micronized Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer",[55],"2021-10","2019-03-01",[32],[892,914],"Endometrin 100Mg Vaginal Insert",{"intervention":914,"totalTrials":98,"cells":916},{"EARLY_PHASE1":917,"PHASE1":919,"PHASE2":921,"PHASE3":923,"PHASE4":925,"NA":927},{"trials":918,"activeCount":61},[],{"trials":920,"activeCount":61},[],{"trials":922,"activeCount":61},[],{"trials":924,"activeCount":61},[],{"trials":926,"activeCount":61},[],{"trials":928,"activeCount":61},[929],{"nctId":907,"briefTitle":908,"status":73,"phases":930,"primaryCompletion":910,"completion":910,"start":911,"enrollment":740,"conditions":931,"interventions":932},[55],[32],[892,914],{"intervention":934,"totalTrials":98,"cells":935},"Bupivacaine",{"EARLY_PHASE1":936,"PHASE1":938,"PHASE2":940,"PHASE3":942,"PHASE4":944,"NA":946},{"trials":937,"activeCount":61},[],{"trials":939,"activeCount":61},[],{"trials":941,"activeCount":61},[],{"trials":943,"activeCount":61},[],{"trials":945,"activeCount":61},[],{"trials":947,"activeCount":61},[948],{"nctId":949,"briefTitle":950,"status":73,"phases":951,"primaryCompletion":952,"completion":952,"start":953,"enrollment":77,"conditions":954,"interventions":956},"NCT02976571","Local and Intraperitoneal Analgetics in Gynecologic Laparoscopy for Post Operative Pain Relief",[55],"2018-12","2016-11",[955],"Postoperative Complications",[934],{"intervention":958,"totalTrials":98,"cells":959},"Ustekinumab Injection [Stelara]",{"EARLY_PHASE1":960,"PHASE1":962,"PHASE2":964,"PHASE3":966,"PHASE4":968,"NA":970},{"trials":961,"activeCount":61},[],{"trials":963,"activeCount":61},[],{"trials":965,"activeCount":61},[],{"trials":967,"activeCount":61},[],{"trials":969,"activeCount":61},[],{"trials":971,"activeCount":61},[972],{"nctId":973,"briefTitle":974,"status":73,"phases":975,"primaryCompletion":976,"completion":977,"start":978,"enrollment":628,"conditions":979,"interventions":981},"NCT04779762","Stelara and Diet Trial for Crohn\"s Disease",[55],"2025-01","2026-01","2022-01",[980],"Crohn Disease",[958],{"intervention":983,"totalTrials":98,"cells":984},"hypertonic saline-salbutamol combination",{"EARLY_PHASE1":985,"PHASE1":987,"PHASE2":989,"PHASE3":991,"PHASE4":993,"NA":995},{"trials":986,"activeCount":61},[],{"trials":988,"activeCount":61},[],{"trials":990,"activeCount":61},[],{"trials":992,"activeCount":61},[],{"trials":994,"activeCount":61},[],{"trials":996,"activeCount":61},[997],{"nctId":998,"briefTitle":999,"status":225,"phases":1000,"primaryCompletion":1001,"completion":1001,"start":1002,"enrollment":1003,"conditions":1004,"interventions":1005},"NCT01073527","Hypertonic Saline as Add on Therapy in Preschool Children With Acute Wheezing Attack.",[55],"2011-07","2009-01",41,[20],[983,1006],"Normal saline-salbutamol combination",{"intervention":1006,"totalTrials":98,"cells":1008},{"EARLY_PHASE1":1009,"PHASE1":1011,"PHASE2":1013,"PHASE3":1015,"PHASE4":1017,"NA":1019},{"trials":1010,"activeCount":61},[],{"trials":1012,"activeCount":61},[],{"trials":1014,"activeCount":61},[],{"trials":1016,"activeCount":61},[],{"trials":1018,"activeCount":61},[],{"trials":1020,"activeCount":61},[1021],{"nctId":998,"briefTitle":999,"status":225,"phases":1022,"primaryCompletion":1001,"completion":1001,"start":1002,"enrollment":1003,"conditions":1023,"interventions":1024},[55],[20],[983,1006],{"intervention":1026,"totalTrials":98,"cells":1027},"Remifentanil",{"EARLY_PHASE1":1028,"PHASE1":1030,"PHASE2":1032,"PHASE3":1034,"PHASE4":1036,"NA":1038},{"trials":1029,"activeCount":61},[],{"trials":1031,"activeCount":61},[],{"trials":1033,"activeCount":61},[],{"trials":1035,"activeCount":61},[],{"trials":1037,"activeCount":61},[],{"trials":1039,"activeCount":61},[1040],{"nctId":1041,"briefTitle":1042,"status":73,"phases":1043,"primaryCompletion":1044,"completion":1045,"start":1046,"enrollment":1047,"conditions":1048,"interventions":1050},"NCT04178785","Remifentanil Versus Fentanyl During Laparoscopic Hysterectomy",[55],"2020-10-22","2020-11-01","2019-10-22",76,[1049],"Anesthesia",[1026],{"intervention":1052,"totalTrials":98,"cells":1053},"Vcinated",{"EARLY_PHASE1":1054,"PHASE1":1056,"PHASE2":1058,"PHASE3":1060,"PHASE4":1062,"NA":1064},{"trials":1055,"activeCount":61},[],{"trials":1057,"activeCount":61},[],{"trials":1059,"activeCount":61},[],{"trials":1061,"activeCount":61},[],{"trials":1063,"activeCount":61},[],{"trials":1065,"activeCount":61},[1066],{"nctId":1067,"briefTitle":1068,"status":73,"phases":1069,"primaryCompletion":1070,"completion":1071,"start":1072,"enrollment":178,"conditions":1073,"interventions":1075},"NCT05034679","Impact of Corona Vaccination on AMH- Anti Mullerian Hormone",[],"2022-08-15","2022-10-15","2021-07-15",[1074],"Patient Participation",[1052],{"intervention":1077,"totalTrials":98,"cells":1078},"Voltaren ophtha 0.1%",{"EARLY_PHASE1":1079,"PHASE1":1081,"PHASE2":1083,"PHASE3":1085,"PHASE4":1087,"NA":1089},{"trials":1080,"activeCount":61},[],{"trials":1082,"activeCount":61},[],{"trials":1084,"activeCount":61},[],{"trials":1086,"activeCount":61},[],{"trials":1088,"activeCount":61},[],{"trials":1090,"activeCount":61},[1091],{"nctId":1092,"briefTitle":1093,"status":73,"phases":1094,"primaryCompletion":1095,"completion":627,"start":1096,"enrollment":740,"conditions":1097,"interventions":1099},"NCT02782338","The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin",[],"2017-05","2016-05",[1098],"Blood Coagulation Disorders",[1077]]